CLINICALLY SIGNIFICANT PROSTATE CANCER
Clinical trials for CLINICALLY SIGNIFICANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CLINICALLY SIGNIFICANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CLINICALLY SIGNIFICANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New blood test could spot dangerous prostate cancer without needle biopsy
Diagnosis Recruiting nowThis study is testing a new blood test that looks for tiny genetic particles (exoRNA) to find clinically significant prostate cancer. The goal is to see if this test can accurately diagnose the disease and reduce the need for invasive biopsies. The study will involve 1700 men wit…
Matched conditions: CLINICALLY SIGNIFICANT PROSTATE CANCER
Sponsor: Xijing Hospital • Aim: Diagnosis
Last updated May 15, 2026 11:53 UTC
-
New PET scan criteria could spare Low-Risk prostate cancer patients from overtreatment
Diagnosis Recruiting nowThis study is testing a new way to read PSMA PET/CT scans, called the Istanbul Criteria, to better identify which men with low-risk prostate cancer can safely choose active surveillance (monitoring) instead of immediate treatment. About 200 men with low-risk prostate cancer will …
Matched conditions: CLINICALLY SIGNIFICANT PROSTATE CANCER
Sponsor: Istanbul University - Cerrahpasa • Aim: Diagnosis
Last updated May 11, 2026 20:47 UTC